Journal articles on the topic 'In Vitro Liver Models'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'In Vitro Liver Models.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
ERKEKOĞLU, Pınar, and Belma KOÇER GÜMÜŞEL. "In Vitro Liver Models in Toxicology." Journal of Literature Pharmacy Sciences 8, no. 1 (2019): 1–17. http://dx.doi.org/10.5336/pharmsci.2018-61664.
Full textGuillouzo, Andre. "Liver Cell Models in in Vitro Toxicology." Environmental Health Perspectives 106 (April 1998): 511. http://dx.doi.org/10.2307/3433803.
Full textGuillouzo, A. "Liver cell models in in vitro toxicology." Environmental Health Perspectives 106, suppl 2 (April 1998): 511–32. http://dx.doi.org/10.1289/ehp.98106511.
Full textWitek, Rafal P., and Jessica A. Bonzo. "Perspective on In Vitro Liver Toxicity Models." Applied In Vitro Toxicology 4, no. 3 (September 2018): 229–31. http://dx.doi.org/10.1089/aivt.2018.29017.wit.
Full textSoldatow, Valerie Y., Edward L. LeCluyse, Linda G. Griffith, and Ivan Rusyn. "In vitro models for liver toxicity testing." Toxicol. Res. 2, no. 1 (2013): 23–39. http://dx.doi.org/10.1039/c2tx20051a.
Full textvan Grunsven, Leo A. "3D in vitro models of liver fibrosis." Advanced Drug Delivery Reviews 121 (November 2017): 133–46. http://dx.doi.org/10.1016/j.addr.2017.07.004.
Full textYe, Shicheng, Jochem W. B. Boeter, Louis C. Penning, Bart Spee, and Kerstin Schneeberger. "Hydrogels for Liver Tissue Engineering." Bioengineering 6, no. 3 (July 5, 2019): 59. http://dx.doi.org/10.3390/bioengineering6030059.
Full textVinken, M. "Liver-based in vitro models for toxicity testing." Toxicology Letters 295 (October 2018): S7. http://dx.doi.org/10.1016/j.toxlet.2018.06.029.
Full textGarcia, Martha C., Margaret Amankwa-Sakyi, and Thomas J. Flynn. "Cellular glutathione in fatty liver in vitro models." Toxicology in Vitro 25, no. 7 (October 2011): 1501–6. http://dx.doi.org/10.1016/j.tiv.2011.05.011.
Full textVan de Bovenkamp, M., G. M. M. Groothuis, D. K. F. Meijer, and P. Olinga. "Liver fibrosis in vitro: Cell culture models and precision-cut liver slices." Toxicology in Vitro 21, no. 4 (June 2007): 545–57. http://dx.doi.org/10.1016/j.tiv.2006.12.009.
Full textOrbach, Sophia M., Rebekah R. Less, Anjaney Kothari, and Padmavathy Rajagopalan. "In Vitro Intestinal and Liver Models for Toxicity Testing." ACS Biomaterials Science & Engineering 3, no. 9 (January 23, 2017): 1898–910. http://dx.doi.org/10.1021/acsbiomaterials.6b00699.
Full textMüller, Fabrice A., and Shana J. Sturla. "Human in vitro models of nonalcoholic fatty liver disease." Current Opinion in Toxicology 16 (August 2019): 9–16. http://dx.doi.org/10.1016/j.cotox.2019.03.001.
Full textMun, Seon Ju, Jaeseo Lee, Yongbo Shin, and Myung Jin Son. "Advanced human liver models for the assessment of drug-induced liver injury." Organoid 2 (July 25, 2022): e17. http://dx.doi.org/10.51335/organoid.2022.2.e17.
Full textBenesic, Andreas, and Alexander L. Gerbes. "Drug-Induced Liver Injury and Individual Cell Models." Digestive Diseases 33, no. 4 (2015): 486–91. http://dx.doi.org/10.1159/000374094.
Full textSari, Gulce, Gertine W. van Oord, Martijn D. B. van de Garde, Jolanda J. C. Voermans, Andre Boonstra, and Thomas Vanwolleghem. "Sexual Dimorphism in Hepatocyte Xenograft Models." Cell Transplantation 30 (January 1, 2021): 096368972110061. http://dx.doi.org/10.1177/09636897211006132.
Full textMiyamoto, Yoshitaka, Yumie Koshidaka, Katsutoshi Murase, Shoichiro Kanno, Hirofumi Noguchi, Kenji Miyado, Takeshi Ikeya, et al. "Functional Evaluation of 3D Liver Models Labeled with Polysaccharide Functionalized Magnetic Nanoparticles." Materials 15, no. 21 (November 5, 2022): 7823. http://dx.doi.org/10.3390/ma15217823.
Full textSun, Lulu, and Lijian Hui. "Progress in human liver organoids." Journal of Molecular Cell Biology 12, no. 8 (April 1, 2020): 607–17. http://dx.doi.org/10.1093/jmcb/mjaa013.
Full textDonato, M. Teresa, Gloria Gallego-Ferrer, and Laia Tolosa. "In Vitro Models for Studying Chronic Drug-Induced Liver Injury." International Journal of Molecular Sciences 23, no. 19 (September 28, 2022): 11428. http://dx.doi.org/10.3390/ijms231911428.
Full textVenkatachalam, Ananda Baskaran, Scott Michael Livingstone, Qianni Hu, Ayush Ray, Caroline Wood, Sanem Cimen, and Ian Patrick Joseph Alwayn. "Delivery of Soluble Heme Oxygenase 1 Cell-Penetrating Peptide into Liver Cells in in vitro and ex vivo Models of Cold Ischemia." European Surgical Research 58, no. 1-2 (November 12, 2016): 51–68. http://dx.doi.org/10.1159/000451079.
Full textvan Tienderen, Groot Koerkamp, IJzermans, van der Laan, and Verstegen. "Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment." Cancers 11, no. 11 (November 1, 2019): 1706. http://dx.doi.org/10.3390/cancers11111706.
Full textDong, Gang, Xiaoquan Huang, Rongxin Chen, Ling Wu, Siyu Jiang, and Shiyao Chen. "Increased PD-L1 Restricts Liver Injury in Nonalcoholic Fatty Liver Disease." Oxidative Medicine and Cellular Longevity 2022 (May 16, 2022): 1–18. http://dx.doi.org/10.1155/2022/5954437.
Full textLee, Sang Woo, Da Jung Jung, and Gi Seok Jeong. "Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models." Tissue Engineering and Regenerative Medicine 17, no. 6 (March 23, 2020): 731–45. http://dx.doi.org/10.1007/s13770-020-00245-9.
Full textLlewellyn, Samantha V., Marije Niemeijer, Penny Nymark, Martijn J. Moné, Bob Water, Gillian E. Conway, Gareth J. S. Jenkins, and Shareen H. Doak. "In Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment." Small 17, no. 15 (January 15, 2021): 2006055. http://dx.doi.org/10.1002/smll.202006055.
Full textHaugabook, Sharie J., Marc Ferrer, and Elizabeth A. Ottinger. "In vitro and in vivo translational models for rare liver diseases." Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865, no. 5 (May 2019): 1003–18. http://dx.doi.org/10.1016/j.bbadis.2018.07.029.
Full textSimeonova, Rumyana, Magdalena Kondeva-Burdina, Vessela Vitcheva, and Mitka Mitcheva. "SomeIn Vitro/In VivoChemically-Induced Experimental Models of Liver Oxidative Stress in Rats." BioMed Research International 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/706302.
Full textYun, Chawon, Sou Hyun Kim, and Young-Suk Jung. "Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells." Pharmaceutics 15, no. 1 (December 24, 2022): 54. http://dx.doi.org/10.3390/pharmaceutics15010054.
Full textSoret, Pierre-Antoine, Julie Magusto, Chantal Housset, and Jérémie Gautheron. "In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal." Journal of Clinical Medicine 10, no. 1 (December 24, 2020): 36. http://dx.doi.org/10.3390/jcm10010036.
Full textArez, Francisca, Ana F. Rodrigues, Catarina Brito, and Paula M. Alves. "Bioengineered Liver Cell Models of Hepatotropic Infections." Viruses 13, no. 5 (April 27, 2021): 773. http://dx.doi.org/10.3390/v13050773.
Full textPelechá, María, Estela Villanueva-Bádenas, Enrique Timor-López, María Teresa Donato, and Laia Tolosa. "Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models." Antioxidants 11, no. 1 (December 30, 2021): 86. http://dx.doi.org/10.3390/antiox11010086.
Full textHerrero, Alba, Elisabeth Knetemann, and Inge Mannaerts. "Review: Challenges of In Vitro CAF Modelling in Liver Cancers." Cancers 13, no. 23 (November 24, 2021): 5914. http://dx.doi.org/10.3390/cancers13235914.
Full textKukla, David A., and Salman R. Khetani. "Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine." Seminars in Liver Disease 41, no. 03 (June 17, 2021): 368–92. http://dx.doi.org/10.1055/s-0041-1731016.
Full textKulkeaw, Kasem. "Next-Generation Human Liver Models for Antimalarial Drug Assays." Antibiotics 10, no. 6 (May 27, 2021): 642. http://dx.doi.org/10.3390/antibiotics10060642.
Full textVergani, Laura. "Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis." Current Medicinal Chemistry 26, no. 19 (September 12, 2019): 3439–56. http://dx.doi.org/10.2174/0929867324666170518101334.
Full textZhang, Xuequn, Yiming Lin, Sisi Lin, Chunxiao Li, Jianguo Gao, Zemin Feng, Jinghua Wang, et al. "Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction." Hepatology International 14, no. 5 (June 30, 2020): 828–41. http://dx.doi.org/10.1007/s12072-020-10068-4.
Full textSassi, Lisa, Omolola Ajayi, Sara Campinoti, Dipa Natarajan, Claire McQuitty, Riccardo Rayan Siena, Sara Mantero, et al. "A Perfusion Bioreactor for Longitudinal Monitoring of Bioengineered Liver Constructs." Nanomaterials 11, no. 2 (January 21, 2021): 275. http://dx.doi.org/10.3390/nano11020275.
Full textCrizer, David M., Sreenivasa C. Ramaiahgari, Stephen S. Ferguson, Julie R. Rice, Paul E. Dunlap, Nisha S. Sipes, Scott S. Auerbach, Bruce Alex Merrick, and Michael J. DeVito. "Benchmark Concentrations for Untargeted Metabolomics Versus Transcriptomics for Liver Injury Compounds in In Vitro Liver Models." Toxicological Sciences 181, no. 2 (March 22, 2021): 175–86. http://dx.doi.org/10.1093/toxsci/kfab036.
Full textTricot, Tine, Catherine M. Verfaillie, and Manoj Kumar. "Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery." Cells 11, no. 3 (January 27, 2022): 442. http://dx.doi.org/10.3390/cells11030442.
Full textYudhani, Ratih D., Yulia Sari, Dwi A. A. Nugrahaningsih, Eti N. Sholikhah, Maftuchah Rochmanti, Abdul K. R. Purba, Husnul Khotimah, Dian Nugrahenny, and Mustofa Mustofa. "In Vitro Insulin Resistance Model: A Recent Update." Journal of Obesity 2023 (January 18, 2023): 1–13. http://dx.doi.org/10.1155/2023/1964732.
Full textHowell, Lawrence, Rosalind E. Jenkins, Stephen Lynch, Carrie Duckworth, B. Kevin Park, and Christopher Goldring. "Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification." Archives of Toxicology 95, no. 7 (May 29, 2021): 2413–30. http://dx.doi.org/10.1007/s00204-021-03075-3.
Full textLee, Seung Yeon, Donghyun Kim, Seung Hwan Lee, and Jong Hwan Sung. "Microtechnology-based in vitro models: Mimicking liver function and pathophysiology." APL Bioengineering 5, no. 4 (December 1, 2021): 041505. http://dx.doi.org/10.1063/5.0061896.
Full textXing, Jia-Li, Yu-Xin Wang, and Shun-Da Du. "Application and research progress of in vitro liver cancer cell culture models." World Chinese Journal of Digestology 29, no. 11 (June 8, 2021): 563–70. http://dx.doi.org/10.11569/wcjd.v29.i11.563.
Full textC. Chavez-Tapia, N., N. Rosso, and C. Tiribelli. "In Vitro Models for the Study of Non-Alcoholic Fatty Liver Disease." Current Medicinal Chemistry 18, no. 7 (March 1, 2011): 1079–84. http://dx.doi.org/10.2174/092986711794940842.
Full textAgarkova, Irina, Simon Messner, Christian Zuppinger, Patrina Gunness, Wolfgang Moritz, Jan G. Hengstler, Magnus Ingelman-Sundberg, and Jens M. Kelm. "Organotypic 3D in vitro microtissue models for cardiac and liver safety assessment." Journal of Pharmacological and Toxicological Methods 70, no. 3 (November 2014): 328. http://dx.doi.org/10.1016/j.vascn.2014.03.068.
Full textPanday, Regeant, Chase P. Monckton, and Salman R. Khetani. "The Role of Liver Zonation in Physiology, Regeneration, and Disease." Seminars in Liver Disease 42, no. 01 (February 2022): 001–16. http://dx.doi.org/10.1055/s-0041-1742279.
Full textCui, J., H. P. Wang, Q. Shi, and T. Sun. "Pulsed Microfluid Force-Based On-Chip Modular Fabrication for Liver Lobule-Like 3D Cellular Models." Cyborg and Bionic Systems 2021 (April 8, 2021): 1–12. http://dx.doi.org/10.34133/2021/9871396.
Full textKEISER, J. "In vitro and in vivo trematode models for chemotherapeutic studies." Parasitology 137, no. 3 (December 7, 2009): 589–603. http://dx.doi.org/10.1017/s0031182009991739.
Full textSchueller, Florian, Sanchari Roy, Sven Heiko Loosen, Jan Alder, Christiane Koppe, Anne Theres Schneider, Franziska Wandrer, et al. "miR-223 represents a biomarker in acute and chronic liver injury." Clinical Science 131, no. 15 (July 13, 2017): 1971–87. http://dx.doi.org/10.1042/cs20170218.
Full textWilson, Garrick K., and Zania Stamataki. "In Vitro Systems for the Study of Hepatitis C Virus Infection." International Journal of Hepatology 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/292591.
Full textBrown, Grace E., and Salman R. Khetani. "Microfabrication of liver and heart tissues for drug development." Philosophical Transactions of the Royal Society B: Biological Sciences 373, no. 1750 (May 21, 2018): 20170225. http://dx.doi.org/10.1098/rstb.2017.0225.
Full textRomualdo, Guilherme Ribeiro, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght, Tereza Cristina da Silva, Luís Fernando Barbisan, et al. "In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling." Cancers 13, no. 21 (November 8, 2021): 5583. http://dx.doi.org/10.3390/cancers13215583.
Full text